These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2605580)

  • 61. [Significance of complex hemodynamic studies for the choice of therapy with the beta-adrenergic blocker, atenolol, and the calcium antagonist, procorum, in patients with ischemic heart disease].
    Ulianova KN; Surovov IuA; Sedov VP; Sidorenko BA
    Kardiologiia; 1992 Feb; 32(2):112. PubMed ID: 1527926
    [No Abstract]   [Full Text] [Related]  

  • 62. [Systolic times of the left ventricle in hypertrophic obstructive cardiomyopathy: effects of beta-adrenergic stimulation and blocking].
    Giovannini E; Ferrari O; Pace F; Milazzotto F
    Boll Soc Ital Cardiol; 1975; 20(11):1595-600. PubMed ID: 1241953
    [No Abstract]   [Full Text] [Related]  

  • 63. The Trial of Antihypertensive Interventions and Management (TAIM) study. Adequate weight loss, alone and combined with drug therapy in the treatment of mild hypertension.
    Wassertheil-Smoller S; Blaufox MD; Oberman AS; Langford HG; Davis BR; Wylie-Rosett J
    Arch Intern Med; 1992 Jan; 152(1):131-6. PubMed ID: 1728908
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [A short-term clinical observation during the treatment of essential hypertension by atenolol composite tablets].
    Zhao GS
    Zhonghua Xin Xue Guan Bing Za Zhi; 1984 Dec; 12(4):274-6. PubMed ID: 6544211
    [No Abstract]   [Full Text] [Related]  

  • 65. Atenolol and chlorthalidone for hypertension in black South Africans.
    Mhlongo SW
    Br Med J; 1980 Dec; 281(6254):1569. PubMed ID: 7437884
    [No Abstract]   [Full Text] [Related]  

  • 66. [Effect of diltiazem on left ventricular function in hypertrophic cardiomyopathy].
    Zhu JR; Li ZS; Zhao HY
    Zhonghua Nei Ke Za Zhi; 1986 Oct; 25(10):584-6, 636. PubMed ID: 3568837
    [No Abstract]   [Full Text] [Related]  

  • 67. Pharmacokinetics of atenolol in hypertensive subjects with and without co-administration of chlorthalidone.
    Riva E; Farina PL; Sega R; Tognoni G; Bastain W; McAinsh J
    Eur J Clin Pharmacol; 1980 May; 17(5):333-7. PubMed ID: 7418712
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Effect of antihypertensive therapy on weight loss. The Trial of Antihypertensive Interventions and Management Research Group.
    Davis BR; Oberman A; Blaufox MD; Wassertheil-Smoller S; Hawkins CM; Cutler JA; Zimbaldi N; Langford HG
    Hypertension; 1992 Apr; 19(4):393-9. PubMed ID: 1555871
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Multicentric clinical study on the antihypertensive efficacy of atenolol administered alone or with a diuretic combination.
    Sala G; Bignotti GC; Ratti G; Mascaretti L; Teruzzi L; Ronchi E; Franzini P; Girelli A; Pilotti A; Santambrogio C
    Farmaco Prat; 1983 Oct; 38(10):369-75. PubMed ID: 6653745
    [No Abstract]   [Full Text] [Related]  

  • 70. Hypertrophic cardiomyopathy.
    Landmark K
    Acta Pharmacol Toxicol (Copenh); 1986; 58 Suppl 2():169-74. PubMed ID: 2424266
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The effects of the beta-blocker atenolol and nitroglycerin on left ventricular function and geometry in man.
    Amende I; Simon R; Hood WP; Lightlen PR
    Circulation; 1979 Oct; 60(4):836-49. PubMed ID: 38916
    [No Abstract]   [Full Text] [Related]  

  • 72. Left ventricular mass reduction during salt depletion in arterial hypertension.
    Ferrara LA; de Simone G; Pasanisi F; Mancini M; Mancini M
    Hypertension; 1984; 6(5):755-9. PubMed ID: 6238910
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Comparison of left ventricular function changes in essential hypertension and hypertrophic non-obstructive cardiomyopathy].
    Fang J; Zeng XH; Luo DC
    Hua Xi Yi Ke Da Xue Xue Bao; 1987 Mar; 18(1):56-9. PubMed ID: 3623523
    [No Abstract]   [Full Text] [Related]  

  • 74. Third-line therapy. A cautionary note.
    Conway J
    Clin Exp Hypertens A; 1985; 7(10):1339-46. PubMed ID: 3907893
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Bioavailability in man of atenolol and chlorthalidone from a combination formulation.
    McAinsh J; Holmes BH; Fitzsimons TJ; Young J
    Biopharm Drug Dispos; 1986; 7(3):223-31. PubMed ID: 3730522
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Diastolic time intervals before and after nadolol in patients with hypertrophic cardiomyopathy.
    Cecchi F; Favilli S; Dolara A; Squillantini G; Zuppiroli A; Ciaccheri M
    Clin Cardiol; 1986 Nov; 9(11):573-4. PubMed ID: 3802605
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Bioavailability in man of atenolol and chlorthalidone from a combination formulation.
    McAinsh J; Bastain W; Young J; Harry JD
    Biopharm Drug Dispos; 1981; 2(2):147-56. PubMed ID: 7248478
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Amiodarone and beta-adrenergic blockers: an interaction with metoprolol but not with atenolol.
    Leor J; Levartowsky D; Sharon C; Farfel Z
    Am Heart J; 1988 Jul; 116(1 Pt 1):206-7. PubMed ID: 3394625
    [No Abstract]   [Full Text] [Related]  

  • 79. [A new association for the treatment of essential arterial hypertension: G 37,736 (hygroton-reserpine)].
    Eisenberg R
    Sem Ther; 1965 Nov; 41(9):525-31. PubMed ID: 5877609
    [No Abstract]   [Full Text] [Related]  

  • 80. Bradyarrhythmia after treatment with atenolol and mirtazapine in a cat with hypertrophic cardiomyopathy.
    Oricco S; Quintavalla C; Apolloni I; Crosara S
    J Vet Cardiol; 2024 Jun; 53():72-76. PubMed ID: 38735230
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.